Martel Rachel A, Lee Victoria, Armstrong Abigail, Demirjian Maral, Kwan Lorna, Al-Safi Zain A
Department of Obstetrics and Gynecology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Department of Obstetrics and Gynecology, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, 27-139 CHS, Los Angeles, CA, 90095-1740, USA.
J Assist Reprod Genet. 2024 Sep;41(9):2359-2366. doi: 10.1007/s10815-024-03212-8. Epub 2024 Jul 25.
We examined the association between progesterone (P4), estradiol (E2), and human chorionic gonadotropin (hCG) levels in early pregnancy and the development of hypertensive diseases of pregnancy among women undergoing assisted reproduction.
Retrospective study including patients who underwent frozen embryo transfer (FET), ovarian stimulation (OS), or unassisted conception (UC) and had a live singleton birth. The primary outcome was the development of hypertensive diseases of pregnancy (gestational hypertension, preeclampsia, HELLP, or eclampsia). Secondary outcomes were the development of fetal intrauterine growth restriction (IUGR), gestational diabetes mellitus, birth weight, and pre-term birth. Hormone levels and the development of the outcomes were correlated.
A total of 681 patients were included; 189 had FET, 193 had OS, and 299 had UC. Patients undergoing FET or OS were not more likely to develop hypertensive diseases of pregnancy compared with UC patients. While median levels of E2 and P4 were significantly different between P-FET and NC-FET patients (E2: 252 vs 317 pg/mL, P4: 64 vs 29 ng/mL, respectively; both p < 0.01), rates of hypertensive diseases of pregnancy did not significantly differ between those two groups. In the multivariate analyses, P4, E2, and hCG were not associated with the development of hypertensive diseases of pregnancy, but progesterone levels were significantly higher among those with IUGR. This remained consistent when the analysis was limited to FET patients.
P4, E2, and hCG levels did not correlate with the development of hypertensive diseases of pregnancy but elevated progesterone levels did correlate with the development of IUGR.
我们研究了妊娠早期孕酮(P4)、雌二醇(E2)和人绒毛膜促性腺激素(hCG)水平与接受辅助生殖的女性妊娠高血压疾病发生之间的关联。
回顾性研究纳入接受冷冻胚胎移植(FET)、卵巢刺激(OS)或自然受孕(UC)并单胎活产的患者。主要结局是妊娠高血压疾病(妊娠期高血压、先兆子痫、HELLP综合征或子痫)的发生。次要结局是胎儿宫内生长受限(IUGR)、妊娠期糖尿病、出生体重和早产的发生。对激素水平与结局的发生进行相关性分析。
共纳入681例患者;189例接受FET,193例接受OS,299例接受UC。与UC患者相比,接受FET或OS的患者发生妊娠高血压疾病的可能性并不更高。虽然P-FET和NC-FET患者之间E2和P4的中位数水平存在显著差异(E2分别为252 vs 317 pg/mL,P4分别为64 vs 29 ng/mL;均p<0.01),但两组妊娠高血压疾病的发生率并无显著差异。在多变量分析中,P4、E2和hCG与妊娠高血压疾病的发生无关,但IUGR患者的孕酮水平显著更高。当分析仅限于FET患者时,这一结果保持一致。
P4、E2和hCG水平与妊娠高血压疾病的发生无关,但孕酮水平升高与IUGR的发生相关。